Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,066Revenue $M8.4Net Margin (%)-691.7Altman Z-Score-2.5
Enterprise Value $M2,802EPS $-1.5Operating Margin %-114.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score475Pre-tax Margin (%)-422.2Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-29.0Quick Ratio23.9Cash flow > EarningsY
Price/Sales1245-y EBITDA Growth Rate %-38.1Current Ratio23.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-20.1Higher Current Ratio y-yY
Dividend Yield %5.7PEG--ROE % (ttm)-444.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M117ROIC % (ttm)-6.7Gross Margin Increase y-yN

Gurus Latest Trades with THRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THRXJoel Greenblatt 2015-03-31 Buy 0.01%$10.68 - $20.2
($15.13)
$ 17.6817%New holding52,837
THRXFirst Eagle Investment 2015-03-31 Add$10.68 - $20.2
($15.13)
$ 17.6817%Add 5.48%1,680,910
THRXSeth Klarman 2014-09-30 Reduce-0.28%$17.53 - $30.4
($22.87)
$ 17.68-23%Reduce 2.84%19,815,983
THRXSeth Klarman 2014-06-30 Reduce-0.23%$21.154 - $30.1
($23.88)
$ 17.68-26%Reduce 1.50%20,395,056
THRXSeth Klarman 2014-03-31 Add0.42%$24.31 - $32.63
($29.32)
$ 17.68-40%Add 2.79%20,705,801
THRXSeth Klarman 2013-12-31 Add1.65%$27.19 - $32.81
($29.19)
$ 17.68-39%Add 8.83%20,144,301
THRXFirst Eagle Investment 2013-12-31 Add0.03%$27.19 - $32.81
($29.19)
$ 17.68-39%Add 23.40%1,509,404
THRXSeth Klarman 2013-09-30 Add2.3%$28.86 - $34.36
($31.06)
$ 17.68-43%Add 11.92%18,510,371
THRXSeth Klarman 2013-06-30 Add2.85%$18.15 - $33.74
($26.83)
$ 17.68-34%Add 22.02%16,538,977
THRXFirst Eagle Investment 2013-06-30 Add0.08%$18.15 - $33.74
($26.83)
$ 17.68-34%Add 139.14%1,109,620
THRXFirst Eagle Investment 2012-06-30 Add0.01%$14.11 - $19.04
($16.72)
$ 17.686%Add 24.23%509,710
THRXSeth Klarman 2012-03-31 Add0.22%$13.21 - $16.28
($13.91)
$ 17.6827%Add 2.30%14,553,800
THRXFirst Eagle Investment 2012-03-31 Add0.01%$13.21 - $16.28
($13.91)
$ 17.6827%Add 25.59%410,310
THRXJulian Robertson 2011-09-30 Sold Out -1.2512%$14.05 - $20.04
($16.74)
$ 17.686%Sold Out0
THRXSeth Klarman 2011-09-30 Add0.84%$14.05 - $20.04
($16.74)
$ 17.686%Add 9.76%14,225,961
THRXFirst Eagle Investment 2011-06-30 Reduce-0.02%$17.07 - $23.13
($20)
$ 17.68-12%Reduce 33.79%326,710
THRXDavid Swensen 2011-03-31 Sold Out -6.58%$16.91 - $20.77
($18.79)
$ 17.68-6%Sold Out0
THRXJulian Robertson 2011-03-31 Reduce-0.35%$16.91 - $20.77
($18.79)
$ 17.68-6%Reduce 20.94%211,686
THRXFirst Eagle Investment 2011-03-31 Add0.02%$16.91 - $20.77
($18.79)
$ 17.68-6%Add 51.02%493,410
THRXWilbur Ross 2011-03-31 Sold Out $16.91 - $20.77
($18.79)
$ 17.68-6%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


THRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Tyree James LDirector 2015-06-02Sell2,438$16.857.24view
WALTRIP WILLIAM HDirector 2015-05-27Sell16,313$16.3210.72view
GLAXOSMITHKLINE PLC10% Owner 2015-05-11Buy85,579$1369260-100view
GLAXOSMITHKLINE PLC10% Owner 2015-03-02Buy92,674$18.060.06view
GLAXOSMITHKLINE PLC10% Owner 2014-11-04Buy832,456$15.3617.64view
LEE JUNNINGSr. VP, Technical Operations 2014-08-13Sell53,424$22.5-19.69view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-08-12Sell28,156$22.13-18.35view
GLAXOSMITHKLINE PLC10% Owner 2014-08-11Buy172,651$22.66-20.26view
GLAXOSMITHKLINE PLC10% Owner 2014-05-09Buy317,770$26.89-32.8view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-03-03Sell65,806$36.73-50.8view

Press Releases about THRX :

Quarterly/Annual Reports about THRX:

News about THRX:

Articles On GuruFocus.com
Insiders' New Buys : MAC, SPB, PDVW, HNSN, THRX, RSG, CVX May 18 2015 
Seth Klarman's Trades During Q1 2015 Apr 20 2015 
Richard Perry's Fourth-Quarter Transactions Had High Impact on Portfolio Feb 16 2015 
Seth Klarman Keeps Buying LNG, KERX, PBF And Keeps Selling THRX Dec 05 2014 
Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function Compared to Tiotropium Oct 17 2014 
Theravance, Inc. Appoints Eric d'Esparbes as Senior Vice President and Chief Financial Officer Oct 15 2014 
Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, Fidel May 15 2014 
Seth Klarman Buys Micron Technology, Theravance, PBF Energy, Sells BP, AIG, Yamana Gold Nov 13 2013 
Seth Klarman's Top 5 Second Quarter Holdings Aug 14 2013 
Top Four from Baupost’s Seth Klarman Jul 18 2013 

More From Other Websites
Theravance Biopharma Announces Marketing Authorization for VIBATIV(R) (Telavancin) in Russia for... Jun 30 2015
HTML PDF Jun 30 2015
HTML PDF Jun 26 2015
5 Biotech Stocks Poised for Breakouts Jun 05 2015
Theravance Biopharma Announces New Employment Inducement Awards Jun 02 2015
Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization... May 27 2015
SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization... May 27 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 20 2015
Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208 for Treatment of... May 20 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 18 2015
Theravance Biopharma Presents Positive Phase 2 Study Data on Velusetrag (TD-5108) for Treatment of... May 18 2015
THERAVANCE INC Financials May 15 2015
5 Stocks Insiders Love Right Now May 13 2015
10-Q for Theravance, Inc. May 10 2015
THERAVANCE INC Files SEC form 10-Q, Quarterly Report May 08 2015
General Releases May 07 2015
Theravance to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference May 07 2015
Theravance Inc Earnings Call scheduled for 5:00 pm ET today May 06 2015
THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 06 2015
Theravance Reports First Quarter 2015 Financial Results May 06 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK